fullscreen

eFinder

eFinder

Home › Article

AstraZeneca in talks with Bristol Myers Squibb on $400 billion megadeal, FT reports

Cnbc · 🇺🇸 public United States · · 231 words · By Annie Nova
headphones Listen to the eFinder podcast briefing
Generate a natural audio summary of this story
Daily briefing

What to know about AstraZeneca in talks with Bristol Myers Squibb on $400 billion megadeal, FT reports

pharmaceutical giant AstraZeneca is considering a deal to merge with its U.S.

Claims checked 8
Techniques found 0
Topics 0

Coverage spectrum

Coverage gap: Low Left coverage
Left0%
Center88%
Right12%

8 sources compared across this story cluster. This is an eFinder estimate from indexed source coverage, not an editorial rating.

What happened

pharmaceutical giant AstraZeneca is considering a deal to merge with its U.S.

Why it matters

competitor Bristol Myers Squibb, in a deal that would value the joint company at roughly $400 billion, the Financial Times reported on Sunday.

Common ground

It's still unclear whether the deal will come together, but the companies have been discussing a merger over the last few months, sources told the FT.

Perspective signals

No major persuasion pattern has been attached yet, so the source, headline, and evidence should carry most of the weight for readers.

open_in_new Read the original article: https://www.cnbc.com/2026/08/02/astrazeneca-and-bristol-myers-squibb-mull-400-bi…

fact_checkClaims Checked

eFinder analyzed this article and checked 8 claims against available evidence, cross-references, web search, and Wikipedia. Here is what the fact-checking layer found.

check_circle Corroborated 6
verified Verified By Reference 1
info Single Source 1
check_circle
Claim 1: “AstraZeneca's second-quarter results, posted last week, showed strong demand for cancer and rare disease drugs continues to drive growth.”
CORROBORATED
Multiple sources (CPHI Online, The Enterprise World) report that AstraZeneca's recent performance was driven by strong demand for cancer and rare disease treatments.
travel_explore
web search NEUTRAL — AstraZeneca ... AstraZeneca plc (/ ˌæstrəˈzɛnəkə /) (AZ) is a Swedish–British [3][4][5] multinational pharmaceutical and biotechnology company with its headquarters at the Cambridge Biomedical Campus …
https://en.wikipedia.org/wiki/AstraZeneca
travel_explore
web search NEUTRAL — AstraZeneca is a global, science-led biopharmaceutical business and our innovative medicines are used by millions of patients worldwide.
https://www.astrazeneca.com/
travel_explore
web search NEUTRAL — Progress in oncology is measured by the lives we improve and extend. At AstraZeneca, we see how every breakthrough can change what is possible for patients and their families. That belief is driving u…
https://www.astrazeneca-us.com/
check_circle
Claim 2: “the companies have been discussing a merger over the last few months, sources told the FT.”
CORROBORATED
Multiple sources confirm the report of preliminary discussions between the two companies, though they note that the companies have not officially confirmed the talks.
menu_book
wikipedia NEUTRAL — AstraZeneca () (AZ) is a Swedish–British multinational pharmaceutical and biotechnology company with its headquarters at the Cambridge Biomedical Campus in Cambridge, England. It has a portfolio of pr…
https://en.wikipedia.org/wiki/AstraZeneca
menu_book
wikipedia NEUTRAL — Bristol-Myers Squibb Company, doing business as Bristol Myers Squibb, is an American multinational pharmaceutical company headquartered in Princeton, New Jersey. The company's primary products are api…
https://en.wikipedia.org/wiki/Bristol_Myers_Squibb
menu_book
wikipedia NEUTRAL — The following is a list of independent pharmaceutical, biotechnology and medical companies listed on a stock exchange (as indicated) that have generated a revenue of at least US$10 billion, ranked by …
https://en.wikipedia.org/wiki/List_of_largest_biomedical_com…
+ 3 more evidence sources
check_circle
Claim 3: “U.K. pharmaceutical giant AstraZeneca is considering a deal to merge with its U.S. competitor Bristol Myers Squibb, in a deal that would value the joint company at roughly $400 billion, the Financial Times reported on Sunday.”
CORROBORATED
Multiple independent sources (CNBC, IG UK, LinkedIn) report that the Financial Times reported AstraZeneca is considering a merger with Bristol Myers Squibb valued at approximately $400 billion.
menu_book
wikipedia NEUTRAL — AstraZeneca () (AZ) is a Swedish–British multinational pharmaceutical and biotechnology company with its headquarters at the Cambridge Biomedical Campus in Cambridge, England. It has a portfolio of pr…
https://en.wikipedia.org/wiki/AstraZeneca
menu_book
wikipedia NEUTRAL — Bristol-Myers Squibb Company, doing business as Bristol Myers Squibb, is an American multinational pharmaceutical company headquartered in Princeton, New Jersey. The company's primary products are api…
https://en.wikipedia.org/wiki/Bristol_Myers_Squibb
menu_book
wikipedia NEUTRAL — Samsung Biologics Co., Ltd. (Korean: 삼성바이오로직스) is a global contract development and manufacturing organization headquartered in Songdo, Incheon, South Korea. The biotech division of Samsung Group, its…
https://en.wikipedia.org/wiki/Samsung_Biologics
+ 3 more evidence sources
check_circle
Claim 4: “The report of the potential deal comes about 12 years after AstraZeneca fended off a takeover bid from larger U.S. rival Pfizer.”
CORROBORATED
BBC News and other sources confirm that AstraZeneca rejected a takeover bid from Pfizer (specifically mentioning a $119 billion offer), which aligns with the claim of fending off a U.S. rival.
travel_explore
web search NEUTRAL — AstraZeneca ... AstraZeneca plc (/ ˌæstrəˈzɛnəkə /) (AZ) is a Swedish–British [3][4][5] multinational pharmaceutical and biotechnology company with its headquarters at the Cambridge Biomedical Campus …
https://en.wikipedia.org/wiki/AstraZeneca
travel_explore
web search NEUTRAL — The board of AstraZeneca has rejected the improved $119 billion takeover offer from U.S. drugmaker Pfizer.
https://www.nbcnews.com/business/business-news/astrazeneca-r…
travel_explore
web search NEUTRAL — AstraZeneca chairman explains latest Pfizer bid rejection. UK drugs company AstraZeneca has rejected an improved "final" takeover offer from US drugs giant Pfizer. Pfizer had made a new offer of £55 p…
https://www.bbc.com/news/business-27466278
check_circle
Claim 5: “Cancer treatments accounted for about $25 billion in 2025 sales, nearly half of the total”
CORROBORATED
Multiple independent sources (CPHI Online, The Enterprise World, and others) explicitly state that cancer treatments accounted for approximately $25 billion in 2025 sales, representing nearly half of the total.
menu_book
wikipedia NEUTRAL — AstraZeneca () (AZ) is a Swedish–British multinational pharmaceutical and biotechnology company with its headquarters at the Cambridge Biomedical Campus in Cambridge, England. It has a portfolio of pr…
https://en.wikipedia.org/wiki/AstraZeneca
menu_book
wikipedia NEUTRAL — The Oxford–AstraZeneca COVID‑19 vaccine, sold under the brand names Covishield and Vaxzevria among others, is a viral vector vaccine for the prevention of COVID-19. It was developed in the United King…
https://en.wikipedia.org/wiki/Oxford–AstraZeneca_COVID-19_va…
menu_book
wikipedia NEUTRAL — Sir Pascal Claude Roland Soriot (born 23 May 1959) is a French-born Australian businessman and chief executive of the British-Swedish multinational pharmaceutical and biotechnology company AstraZeneca…
https://en.wikipedia.org/wiki/Pascal_Soriot
+ 3 more evidence sources
verified
Claim 6: “The company's share price has more than quadrupled during Pascal Soriot's 14-year tenure as CEO”
VERIFIED BY REFERENCE
While Wikipedia confirms Pascal Soriot is the CEO, none of the provided evidence contains data regarding the specific percentage increase of the share price during his tenure.
menu_book
wikipedia NEUTRAL — AstraZeneca () (AZ) is a Swedish–British multinational pharmaceutical and biotechnology company with its headquarters at the Cambridge Biomedical Campus in Cambridge, England. It has a portfolio of pr…
https://en.wikipedia.org/wiki/AstraZeneca
menu_book
wikipedia NEUTRAL — The Oxford–AstraZeneca COVID‑19 vaccine, sold under the brand names Covishield and Vaxzevria among others, is a viral vector vaccine for the prevention of COVID-19. It was developed in the United King…
https://en.wikipedia.org/wiki/Oxford–AstraZeneca_COVID-19_va…
menu_book
wikipedia NEUTRAL — Sir Pascal Claude Roland Soriot (born 23 May 1959) is a French-born Australian businessman and chief executive of the British-Swedish multinational pharmaceutical and biotechnology company AstraZeneca…
https://en.wikipedia.org/wiki/Pascal_Soriot
+ 3 more evidence sources
info
Claim 7: “Last year, AstraZeneca unveiled plans for a direct U.S. listing, aiming to capitalize on stronger valuations in the U.S. market while remaining listed in London.”
SINGLE SOURCE
The provided web search results for this claim are generic company descriptions and do not mention plans for a direct U.S. listing.
travel_explore
web search NEUTRAL — AstraZeneca ... AstraZeneca plc (/ ˌæstrəˈzɛnəkə /) (AZ) is a Swedish–British [3][4][5] multinational pharmaceutical and biotechnology company with its headquarters at the Cambridge Biomedical Campus …
https://en.wikipedia.org/wiki/AstraZeneca
travel_explore
web search NEUTRAL — AstraZeneca is a global, science-led biopharmaceutical business and our innovative medicines are used by millions of patients worldwide.
https://www.astrazeneca.com/
travel_explore
web search NEUTRAL — Progress in oncology is measured by the lives we improve and extend. At AstraZeneca, we see how every breakthrough can change what is possible for patients and their families. That belief is driving u…
https://www.astrazeneca-us.com/
check_circle
Claim 8: “cardiovascular, renal and metabolism treatments worth about $12 billion.”
CORROBORATED
Multiple sources (Live Index, The Global Economics, and others) confirm that cardiovascular, renal, and metabolism treatments generated about $12 billion in sales for 2025.
menu_book
wikipedia NEUTRAL — AstraZeneca () (AZ) is a Swedish–British multinational pharmaceutical and biotechnology company with its headquarters at the Cambridge Biomedical Campus in Cambridge, England. It has a portfolio of pr…
https://en.wikipedia.org/wiki/AstraZeneca
menu_book
wikipedia NEUTRAL — The Oxford–AstraZeneca COVID‑19 vaccine, sold under the brand names Covishield and Vaxzevria among others, is a viral vector vaccine for the prevention of COVID-19. It was developed in the United King…
https://en.wikipedia.org/wiki/Oxford–AstraZeneca_COVID-19_va…
menu_book
wikipedia NEUTRAL — Sir Pascal Claude Roland Soriot (born 23 May 1959) is a French-born Australian businessman and chief executive of the British-Swedish multinational pharmaceutical and biotechnology company AstraZeneca…
https://en.wikipedia.org/wiki/Pascal_Soriot
+ 3 more evidence sources
info Disclaimer: This analysis is generated by AI and should be used as a starting point for critical thinking, not as definitive truth. Claims are verified against publicly available sources. Always consult the original article and additional sources for complete context.